Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Bachem Holding AG
  6. Summary
    BANB   CH0012530207

BACHEM HOLDING AG

(BANB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
06/11/2021 06/14/2021 06/15/2021 06/16/2021 06/17/2021 Date
529(c) 534(c) 553(c) 516(c) 521(c) Last
9 208 13 564 16 818 26 487 23 007 Volume
+1.34% +0.95% +3.56% -6.69% +0.97% Change
More quotes
Financials
Sales 2021 479 M 522 M 522 M
Net income 2021 101 M 110 M 110 M
Net Debt 2021 146 M 159 M 159 M
P/E ratio 2021 72,1x
Yield 2021 0,67%
Sales 2022 565 M 615 M 615 M
Net income 2022 124 M 135 M 135 M
Net Debt 2022 161 M 175 M 175 M
P/E ratio 2022 58,7x
Yield 2022 0,73%
Capitalization 7 292 M 7 954 M 7 945 M
EV / Sales 2021 15,5x
EV / Sales 2022 13,2x
Nbr of Employees 1 475
Free-Float 42,9%
More Financials
Company
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the... 
More about the company
Ratings of Bachem Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about BACHEM HOLDING AG
07:38aBACHEMá : Mirabaud Securities Lifts Price Target on Bachem, Maintains Buy Recomm..
MT
06/15BACHEMá : A world market leader from the Basel region – Bachem celebrates ..
PU
06/14BACHEMá : What are Amino Acids?
PU
06/10BACHEMá : Antimicrobial Peptides
PU
06/08BACHEMá : recognized as a winner at the Swiss Biotech Success Stories Awards 202..
PU
06/04BACHEMá : What is GMP?
PU
05/27BACHEMá : Amyloid Beta Peptides & Alzheimer's Disease
PU
05/27PRESS RELEASE : Santhera Publishes Agenda for its Annual General Meeting
DJ
05/25BACHEMá : Will Targeting Alpha-Synuclein Lead to Treatments for Parkinson's Dise..
PU
05/11MEET BACHEM : Swetlana Meinhardt, Category Manager
PU
05/07BACHEMá : Peptides unlock doors to understand Parkinson's disease
PU
05/03BACHEMá : Interview with Robert Yu, CEO of Yuyu Pharma
PU
04/30BACHEM HOLDING AG : Ex-dividend day for final dividend
FA
04/30BACHEM HOLDING AG : Ex-dividend day for Distribution from share premium account
FA
04/29BACHEMá : What are peptides?
PU
More news
News in other languages on BACHEM HOLDING AG
06/16Aktien Schweiz: SMI bleibt unter 12'000 Punkten - Warten auf US-Notenbank
06/16Aktien Schweiz: Weiter fest, aber unter Tageshoch
06/15Aktien Schweiz Schluss: SMI beisst sich an 12'000er-Marke Zähne aus
06/10Aktien Schweiz Schluss: Novartis hieven SMI ins Plus
06/08Aktien Schweiz: Erneut fester - Schwergewichte halten SMI auf Rekordkurs
More news
Analyst Recommendations on BACHEM HOLDING AG
More recommendations
Stock Trading Strategies
BACHEM HOLDING AG - 05/21
Good timing to anticipate a continuation of the trend
BUY
More Stock Trading Analysis
Chart BACHEM HOLDING AG
Duration : Period :
Bachem Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BACHEM HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 501,67 CHF
Last Close Price 521,00 CHF
Spread / Highest target 15,2%
Spread / Average Target -3,71%
Spread / Lowest Target -24,2%
EPS Revisions
Managers and Directors
NameTitle
Thomas Meier Chief Executive Officer
Alain Schaffter Chief Financial Officer
Kuno Sommer Chairman
GŘnther Loidl Chief Technology Officer
Ralph Sch÷nleber Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
BACHEM HOLDING AG30.47%8 032
MODERNA, INC.89.37%79 438
LONZA GROUP AG17.02%54 990
IQVIA HOLDINGS INC.36.31%46 809
CELLTRION, INC.-25.07%33 149
SEAGEN INC.-13.60%27 461